Subscribe To
Olema oncology to participate in upcoming investor conferences in november
SAN FRANCISCO, Nov. 01, 2023 (GLOBE NEWSWIRE) — Olema Pharmaceuticals, Inc. (“Olema”, “Olema Oncology”, Nasdaq: OLMA), a clinical-...
November 1, 2023, 8:27 pm
Usd/jpy forecast: takes off against the yen
The USD/JPY staged a substantial rally during Tuesday’s trading session, largely spurred by the Bank ...
November 1, 2023, 7:29 pm
Hillevax to present at upcoming investor conferences
BOSTON, Nov. 01, 2023 (GLOBE NEWSWIRE) -- HilleVax, Inc. (Nasdaq: HLVX), a clinical-stage biopharmaceut...
November 1, 2023, 4:48 pm
Cellectis to report third quarter 2023 financial results on november 6, 2023
NEW YORK, Nov. 01, 2023 (GLOBE NEWSWIRE) -- Cellectis (the “Company”) (Euronext Growth: ALCLS- NASDAQ: CLLS), a clinical-...
November 1, 2023, 4:30 pm
Olema oncology to participate in upcoming investor conferences in november
SAN FRANCISCO, Nov. 01, 2023 (GLOBE NEWSWIRE) -- Olema Pharmaceuticals, Inc. (“Olema”, “Olema Oncology”, Nasdaq: OLMA), a clinical-...
November 1, 2023, 4:27 pm
Gracell biotechnologies to participate in four upcoming investor conferences
SAN DIEGO and SUZHOU, China and SHANGHAI, China, Nov. 01, 2023 (GLOBE NEWSWIRE) -- Gracell Biotechnologies Inc. ("Gracell" or the "Company", NASDA...
November 1, 2023, 4:00 pm
Usd/jpy forecast: intervention threats pause yen’s decline
Market participants expect that US interest rates will remain unchanged. The yen plunged 1.7% on Tuesday, reaching a one-year low of 151.74 per dollar...
November 1, 2023, 2:29 pm
Stocks stage comeback ahead of fed decision: what to do now
Investors will be keying in on Fed Chairman Jerome Powell's commentary during the usual post-meeting press conference....
November 1, 2023, 2:17 pm
Processa pharmaceuticals announces formation of oncology advisory board with renowned key opinion leaders
Company To Leverage World-Class Oncology Advisory Board in the Design of Oncology Trial Protocols, Including the Anticipated Phase 2 Trial for NGC-Cap...
November 1, 2023, 12:15 pm
Masonic cancer center, university of minnesota to present data in poster presentation human data readout for phase 1 study to evaluate hcw9218 in solid tumors at sitc 38th annual meeting
HCW9218 is the lead product candidate of HCW Biologics Inc. MIRAMAR, Fla., Nov. 01, 2023 (GLOBE NEWSWIRE) — HCW Biologics Inc. (the “Company” or...
November 1, 2023, 11:30 am
Sensei biotherapeutics appoints stephanie krebs, ms, mba, as chief business officer
BOSTON, Nov. 01, 2023 (GLOBE NEWSWIRE) — Sensei Biotherapeutics, Inc. (Nasdaq: SNSE), a clinical stage...
November 1, 2023, 11:30 am
Celcuity to present at upcoming stifel and jefferies investor conferences
MINNEAPOLIS, Nov. 01, 2023 (GLOBE NEWSWIRE) — Celcuity Inc. (Nasdaq: CELC), a clinical-stage biotechn...
November 1, 2023, 11:05 am
Springworks therapeutics announces presentation of additional data from phase 3 defi trial of nirogacestat in adults with desmoid tumors at the 2023 ctos annual meeting
– Nirogacestat Treatment Demonstrated Rapid and Sustained Improvements in Functional Status Compared to Placebo Across Multiple Assessment Tools –...
November 1, 2023, 10:30 am
Usd/jpy forecast: intervention threats pause yen’s decline
Market participants expect that US interest rates will remain unchanged. The yen plunged 1.7% on Tuesday, reaching a one-year low of 151.74 per dollar...
November 1, 2023, 9:52 am
Can videogame makers stage a turnaround from the 2022 lows?
Videogame sales are steadily rebounding, helping stocks like Microsoft Corporation (MSFT), Electronic Arts (EA) and Nintendo (NTDOY)....
November 1, 2023, 9:46 am
Anaptys announces participation in november investor conferences
SAN DIEGO, Nov. 01, 2023 (GLOBE NEWSWIRE) -- AnaptysBio, Inc. (Nasdaq: ANAB), a clinical-stage biotechn...
November 1, 2023, 9:15 am
Zymeworks announces participation in upcoming investor conferences
VANCOUVER, British Columbia, Nov. 01, 2023 (GLOBE NEWSWIRE) -- Zymeworks Inc. (Nasdaq: ZYME), a clinical-stage...
November 1, 2023, 8:30 am
Aptevo to present at bio-europe conference
SEATTLE, WA / ACCESSWIRE / November 1, 2023 / Aptevo Therapeutics Inc. (NASDAQ:APVO), a clinical-stage ...
November 1, 2023, 7:45 am
Fed in focus
Market movers today The key market mover today will be the FOMC meeting tonight. We expect the Fed to stay on hold in line with consensus and market e...
November 1, 2023, 7:21 am
Celcuity to present at upcoming stifel and jefferies investor conferences
MINNEAPOLIS, Nov. 01, 2023 (GLOBE NEWSWIRE) -- Celcuity Inc. (Nasdaq: CELC), a clinical-stage biotechno...
November 1, 2023, 7:05 am